LISSONI ANDREA ALBERTO

Marino, G., Grassi, T., De Ponti, E., Testa, F., Negri, S., Giuliani, D., et al. (2024). Fertility outcomes in stage I ovarian immature teratomas. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 34(9), 1416-1422 [10.1136/ijgc-2024-005534]. Dettaglio

Marino, G., Grassi, T., De Ponti, E., Negri, S., Testa, F., Giuliani, D., et al. (2024). Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy. FRONTIERS IN ONCOLOGY, 14 [10.3389/fonc.2024.1330481]. Dettaglio

Colombo, N., Biagioli, E., Harano, K., Galli, F., Hudson, E., Antill, Y., et al. (2024). Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. THE LANCET ONCOLOGY, 25(9), 1135-1146 [10.1016/S1470-2045(24)00334-6]. Dettaglio

Bianchi, T., Grassi, T., Bazzurini, L., Testa, F., Corti, J., Pecis Cavagna, G., et al. (2024). The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 50(9 (September 2024)) [10.1016/j.ejso.2024.108523]. Dettaglio

Polano, M., Bedon, L., Dal Bo, M., Sorio, R., Bartoletti, M., De Mattia, E., et al. (2023). Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab. CLINICAL PHARMACOLOGY & THERAPEUTICS, 114(3), 652-663 [10.1002/cpt.2960]. Dettaglio